Warfarin vs Aspirin in Reduced Ejection Fraction -STAT
Warfarin vs Aspirin in Reduced Ejection Fraction -STAT
批准号:
7430249
负责人:
JOHN L THOMPSON
金额:
$20.0万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2008-02-29
关键词:
AddressAfrican AmericanAlgorithmsAnticoagulationAspirinAtrial FibrillationCardiacCerebral hemisphere hemorrhageCerebrumCessation of lifeChronicClassClinicalClinical TrialsClinical Trials, OtherCommunicationDataDouble-Blind MethodEFRACEnd PointEnrollmentEnsureEquilibriumEtiologyFibrinolytic AgentsFunctional disorderGoalsHeart DiseasesHeart failureInfarctionInternational Normalized RatioInterventionIschemic StrokeLeftLeft Ventricular Ejection FractionLinkMedication ManagementMulti-Institutional Clinical TrialMyocardial InfarctionMyocardial IschemiaOperative Surgical ProceduresPatientsPrincipal InvestigatorProtocols documentationQuality ControlRandomizedRangeRateRelative (related person)Relative RisksReportingResearchResearch PersonnelRiskRisk ReductionSafetySideSpecific qualifier valueStrokeSubgroupTestingTimeTo specifyUpper armVentricularWarfarinWomanclinical research sitecognitive functiondata managementdaydesignexperiencefollow-uphazardmenmortalitypatient safetypreventsize
中文摘要
点击翻译按钮获取中文摘要
英文摘要
WARCEF-STAT and WARCEF-CLIN are two separate but highly coordinated units which together constitute WARCEF,
a two-arm (1:1) double-blind randomized multicenter clinical trial (target enrollment 2860 patients at 70 clinical sites)
designed to test the primary null hypothesis of no difference between warfarin (INR 2.5-3, target 2.75) and aspirin (325
mg/day) in 3-5 year survival for the composite endpoint death or stroke or intracerebral hemorrhage among patients with
low (<=30%) cardiac Left Ventricular Ejection Fraction (LVEF). Prespecified secondary hypotheses are tested for
subgroups of women and African Americans, and for the endpoint of stroke alone. Prespecified tertiary hypotheses are
tested by amalgamating data from WARCEF and another trial (WATCH). The goals of WARCEF-STAT are: 1) to
conduct, efficiently integrate, and be responsible for all WARCEF data management, double-blinding, medication
management, quality control, and reporting operations. 2) to specify, conduct and be responsible for all interim, safety,
and final statistical analyses for WARCEF and for the reporting of these results. 3) to transmit to the Clinical Coordinating
Center (CCC) in a timely fashion all of the data which the principal investigator of WARCEF-CLIN needs to meet his
responsibilities in terms of ensuring patient safety and directing all clinical operations. Goal 1 is accomplished by
integrating a Data Management Center with substantial experience in cardiac trials and an anticoagulation unit which is
successfully conducting an ongoing double blind warfarin-aspirin study (WARSS). The double-blind algorithm used in
WARSS to fabricate INRs for patients on active aspirin will be recalibrated and revalidated for the WARCEF target range
before WARCEF begins. Goal 2 is achieved by a statistical analysis unit that is experienced in stroke, cardiac, and other
clinical trials. Goal 3 is ensured by an Operations Committee of WARCEF-STAT and WARCEF-CLIN investigators and
senior coordinators which meets frequently under tightly specified and controlled communication protocols.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biostatistics and Data Management Core
-
批准号:7560928
-
项目类别:
-
资助金额:$28.76万
-
财政年份:2007
-
负责人:JOHN L THOMPSON
-
依托单位:
Phase IIB Study of TNK in Acute Stroke (TNK-S2B-STAT)
-
批准号:7243461
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2004
-
负责人:JOHN L THOMPSON
-
依托单位:
Phase IIB Study of TNK in Acute Stroke (TNK-S2B-STAT)
-
批准号:7071718
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2004
-
负责人:JOHN L THOMPSON
-
依托单位:
Clinical Trial of High Dose CoQ10 in ALS-QALS-=STAT
-
批准号:7222663
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2004
-
负责人:JOHN L THOMPSON
-
依托单位:
Phase IIB Study of TNK in Acute Stroke (TNK-S2B-STAT)
-
批准号:6887684
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2004
-
负责人:JOHN L THOMPSON
-
依托单位:
Clinical Trial of High Dose CoQ10 in ALS-QALS-=STAT
-
批准号:7046790
-
项目类别:
-
资助金额:$27.94万
-
财政年份:2004
-
负责人:JOHN L THOMPSON
-
依托单位:
Clinical Trial of High Dose CoQ10 in ALS-QALS-=STAT
-
批准号:6768461
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2004
-
负责人:JOHN L THOMPSON
-
依托单位:
Clinical Trial of High Dose CoQ10 in ALS-QALS-=STAT
-
批准号:6874859
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2004
-
负责人:JOHN L THOMPSON
-
依托单位:
Phase IIB Study of TNK in Acute Stroke (TNK-S2B-STAT)
-
批准号:6776282
-
项目类别:
-
资助金额:$51.88万
-
财政年份:2004
-
负责人:JOHN L THOMPSON
-
依托单位:
Phase IIB Study of TNK in Acute Stroke (TNK-S2B-STAT)
-
批准号:7796985
-
项目类别:
-
资助金额:$14.12万
-
财政年份:2004
-
负责人:JOHN L THOMPSON
-
依托单位:
Warfarin vs Aspirin in Reduced Ejection Fraction -STAT
-
批准号:6529441
-
项目类别:
-
资助金额:$198.3万
-
财政年份:2001
-
负责人:JOHN L THOMPSON
-
依托单位:
Warfarin vs Aspirin in Reduced Ejection Fraction - STAT
-
批准号:7927908
-
项目类别:
-
资助金额:$553.42万
-
财政年份:2001
-
负责人:JOHN L THOMPSON
-
依托单位:
Warfarin vs Aspirin in Reduced Ejection Fraction -STAT
-
批准号:7067217
-
项目类别:
-
资助金额:$199.51万
-
财政年份:2001
-
负责人:JOHN L THOMPSON
-
依托单位:
Warfarin vs Aspirin in Reduced Ejection Fraction -STAT
-
批准号:6332249
-
项目类别:
-
资助金额:$168.49万
-
财政年份:2001
-
负责人:JOHN L THOMPSON
-
依托单位:
Warfarin vs Aspirin in Reduced Ejection Fraction - STAT
-
批准号:7929487
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2001
-
负责人:JOHN L THOMPSON
-
依托单位:
Warfarin vs Aspirin in Reduced Ejection Fraction - STAT
-
批准号:7499021
-
项目类别:
-
资助金额:$216.84万
-
财政年份:2001
-
负责人:JOHN L THOMPSON
-
依托单位:
Warfarin vs Aspirin in Reduced Ejection Fraction -STAT
-
批准号:6874898
-
项目类别:
-
资助金额:$208.13万
-
财政年份:2001
-
负责人:JOHN L THOMPSON
-
依托单位:
Warfarin vs Aspirin in Reduced Ejection Fraction - STAT
-
批准号:7319454
-
项目类别:
-
资助金额:$260.77万
-
财政年份:2001
-
负责人:JOHN L THOMPSON
-
依托单位:
Warfarin vs Aspirin in Reduced Ejection Fraction -STAT
-
批准号:6654436
-
项目类别:
-
资助金额:$204.31万
-
财政年份:2001
-
负责人:JOHN L THOMPSON
-
依托单位:
海外基金